Biotechnology instruments market seen reaching $111.27 billion by 2030

The Business Research Company says the biotechnology instruments market is projected to grow from $80.9 billion in 2025 to $86.43 billion in 2026, with North America leading today and Asia-Pacific expected to grow fastest through 2030. Rising chronic disease rates, lab automation and AI-driven research are among the main forces behind the expansion.

Why it matters: - The biotechnology instruments market underpins research, diagnostics and product development across medicine, agriculture and environmental science. - Faster market growth points to stronger demand for lab automation, high-throughput analysis and clinical diagnostic tools. - Expanding chronic disease rates increase the need for better testing, treatment support and drug discovery tools.

What happened: - The Business Research Company published a new biotechnology instruments market report covering market size, trends and a global forecast through 2035. - The market is projected to grow from $80.9 billion in 2025 to $86.43 billion in 2026. - The report projects the market will reach $111.27 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - The 2026 forecast implies a 6.8% compound annual growth rate. - The 2030 forecast implies a 6.5% compound annual growth rate. - Historical growth has been supported by limited automation in biotech labs, manual sample processing, rising pharmaceutical and biotech research, conventional diagnostic use and stronger demand for laboratory consumables. - Future growth drivers include advanced laboratory automation tools, artificial intelligence, robotics, broader genomics and proteomics studies, higher pharmaceutical R&D investment and cloud-based data management platforms. - Key trends include greater use of lab automation instruments, more demand for high-throughput screening and analysis, expansion of proteomics and genomics research, more clinical diagnostic use for in vitro diagnostic instruments and tighter focus on quality control and regulatory compliance. - Biotechnology instruments are specialized devices and tools used in biotech laboratories for research, product development and biological processes. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies and future trends, plus updated graphics and tables. - The company offered a free sample report at Download a free sample. - The full report is available at View the full report.

Between the lines: - Chronic disease growth is a major demand signal because more patients increase pressure on diagnostics, treatment development and drug candidate screening. - The shift toward AI, robotics and cloud tools suggests biotechnology labs are moving from manual workflows toward more automated and data-heavy systems. - Regional leadership is shifting gradually, with North America still dominant but Asia-Pacific positioned to capture faster expansion. - The report’s added scoring tools and dashboards suggest buyers are looking for more decision-ready market intelligence, not just raw forecasts.

What's next: - The market is expected to keep expanding as lab automation, genomics and proteomics research and pharmaceutical R&D investment deepen. - Adoption of cloud-based data management platforms should continue to shape biotech workflows through 2030. - Regulatory and quality-control requirements are likely to remain a central buying criterion for biotech instrument users. - The Business Research Company is inviting readers to contact its experts for more information and sales support.